These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6252782

  • 41. Increase in 15-hydroxyprostaglandin dehydrogenase activity in the ovine placentome at parturition and effect of oestrogen.
    Riley SC, Leask R, Selkirk JV, Kelly RW, Brooks AN, Howe DC.
    J Reprod Fertil; 2000 Jul; 119(2):329-38. PubMed ID: 10864846
    [Abstract] [Full Text] [Related]

  • 42. Prostaglandin E2 is only slightly metabolized in the fetal circulation of perfused human placenta.
    Ekblad U, Erkkola R, Uotila P.
    Prostaglandins Leukot Med; 1982 May; 8(5):481-8. PubMed ID: 6954552
    [Abstract] [Full Text] [Related]

  • 43. Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous.
    Sun FF, Taylor BM, Lincoln FH, Sebek OK.
    Prostaglandins; 1980 Oct; 20(4):729-33. PubMed ID: 6258195
    [Abstract] [Full Text] [Related]

  • 44. Kinetic studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Jarabak J, Braithwaite SS.
    Arch Biochem Biophys; 1976 Nov; 177(1):245-54. PubMed ID: 187123
    [No Abstract] [Full Text] [Related]

  • 45. Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua.
    Okazaki T, Casey ML, Okita JR, MacDonald PC, Johnston JM.
    Am J Obstet Gynecol; 1981 Feb 15; 139(4):373-81. PubMed ID: 6781352
    [Abstract] [Full Text] [Related]

  • 46. Studies on 15-hydroxyprostaglandin dehydrogenase with various prostaglandin analogues.
    Ohno H, Morikawa Y, Hirata F.
    J Biochem; 1978 Dec 15; 84(6):1485-94. PubMed ID: 216666
    [Abstract] [Full Text] [Related]

  • 47. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
    Clish CB, Sun YP, Serhan CN.
    Biochem Biophys Res Commun; 2001 Nov 09; 288(4):868-74. PubMed ID: 11688989
    [Abstract] [Full Text] [Related]

  • 48. Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung HS, Harvey RG, Armstrong RN, Jarabak J.
    J Biol Chem; 1987 Sep 15; 262(26):12448-51. PubMed ID: 3624267
    [Abstract] [Full Text] [Related]

  • 49. Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle.
    Michelet JF, Colombe L, Gautier B, Gaillard O, Benech F, Pereira R, Boulle C, Dalko-Csiba M, Rozot R, Neuwels M, Bernard BA.
    Exp Dermatol; 2008 Oct 15; 17(10):821-8. PubMed ID: 18328086
    [Abstract] [Full Text] [Related]

  • 50. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
    Patel FA, Sun K, Challis JR.
    J Clin Endocrinol Metab; 1999 Feb 15; 84(2):395-400. PubMed ID: 10022390
    [Abstract] [Full Text] [Related]

  • 51. Prostaglandin endoperoxide analogues and prostaglandid D2 as substrates of human placental 15-hydroxy prostaglandin dehydrogenase.
    Ruckrich MF, Schlegel W, Jung A.
    FEBS Lett; 1976 Sep 15; 68(1):59-62. PubMed ID: 964381
    [No Abstract] [Full Text] [Related]

  • 52. Differences between 15-hydroxyprostaglandin dehydrogenase from pig placenta and human placenta [proceedings].
    Bradbear N, Jeffery J.
    Biochem Soc Trans; 1978 Sep 15; 6(6):1164-5. PubMed ID: 33855
    [No Abstract] [Full Text] [Related]

  • 53. Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
    Ensor CM, Tai HH.
    Biochim Biophys Acta; 1994 Sep 21; 1208(1):151-6. PubMed ID: 8086429
    [Abstract] [Full Text] [Related]

  • 54. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.
    Jarabak J.
    Arch Biochem Biophys; 1992 Jan 21; 292(1):239-43. PubMed ID: 1309294
    [Abstract] [Full Text] [Related]

  • 55. Photoaffinity labeling of human placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase with [alpha-32P]2N3NAD+. Identification of a peptide in the adenine ring binding domain.
    Chavan AJ, Ensor CM, Wu P, Haley BE, Tai HH.
    J Biol Chem; 1993 Aug 05; 268(22):16437-42. PubMed ID: 8344929
    [Abstract] [Full Text] [Related]

  • 56. 15-Hydroxyprostaglandin dehydrogenase.
    Ensor CM, Tai HH.
    J Lipid Mediat Cell Signal; 1995 Oct 05; 12(2-3):313-9. PubMed ID: 8777575
    [Abstract] [Full Text] [Related]

  • 57. Prostaglandin E(2) 9-keto reductase activity in bovine retained and not retained placenta.
    Kankofer M, Wierciński J, Zerbe H.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr 05; 66(4):413-7. PubMed ID: 12054911
    [Abstract] [Full Text] [Related]

  • 58. Metabolism of prostacyclin in blood vessels.
    Wong PY, Sun FF, McGiff JC.
    J Biol Chem; 1978 Aug 25; 253(16):5555-7. PubMed ID: 27516
    [Abstract] [Full Text] [Related]

  • 59. Distribution of prostaglandin E 9-ketoreductase and NAD+-dependent and NADP+-dependent 15-hydroxyprostaglandin dehydrogenase in the renal cortex and medulla of various species.
    Katzen DR, Pong SS, Levine L.
    Res Commun Chem Pathol Pharmacol; 1975 Dec 25; 12(4):781-7. PubMed ID: 2961
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.